Research and development

05.10.2017, 08:33
Microbes in permafrost are major contributors to climate change, research shows.
04.10.2017, 08:17
New research says volcanic eruptions can contribute to El Niño weather events, a finding that could lead to better predictions for coming seasons.
04.10.2017, 08:15
Chronic bronchitis is a precursor to the deadly and incurable COPD, but there is no test to diagnose the disease. New research could change that.
04.10.2017, 07:16
A new analysis suggests that open-ocean aquaculture for three species of finfish is a viable option for industry expansion under most climate change scenarios – an option that may provide a new source of protein for the world’s growing population
03.10.2017, 13:36
MIT alumnus and two others honored for discovering the molecular mechanisms of circadian rhythms.
03.10.2017, 13:33
Drug already in clinical trials may be effective on some aggressive adenocarcinomas.
03.10.2017, 13:28
Recently discovered phenomenon could provide a way to bypass the limits to Moore’s Law.
03.10.2017, 10:38
Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams
03.10.2017, 08:00
Creating a process called endocytosis on demand could lead to new ways to deliver drugs directly to cells.
02.10.2017, 09:32
Alcon introduces new innovations in cataract surgery at European Society of Cataract & Refractive Surgeons 2017 annual congress
02.10.2017, 08:38
Mantis shrimp have mushroom bodies in their brains. Here's why that's even weirder than it sounds.
02.10.2017, 08:36
A new laser-based way to quickly and accurately detect explosives, even from remote locations, could one day be used at airports and on the battlefield.
29.09.2017, 17:10
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has filed a Registration Statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) for a rights offering to existing holders of its common stock
29.09.2017, 14:00
Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced financial results for the half-year ended June 30, 2017
28.09.2017, 09:53
Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets

Комментарии

Для добавления комментария необходимо войти под своей учётной записью или зарегистрироваться.
Комментариев нет

All news in one column

News archive for the month

декабрь, 2024
motuwethfrsasu
2526272829301
2345678
9101112131415
16171819202122
23242526272829
303112345